Pharma Diagnostics

Asse, Belgium Founded: 2007 • Age: 19 yrs
Biomolecular interactions are analyzed via plate-based LSPR assays.
Request Access

About Pharma Diagnostics

Pharma Diagnostics is a company based in Asse (Belgium) founded in 2007.. Pharma Diagnostics has raised $7.4 million across 2 funding rounds from investors including PMV, Cap-E and Capital E. The company has 8 employees as of December 31, 2015. Pharma Diagnostics operates in a competitive market with competitors including Carterra, Nicoya Life, Riot Platforms, FOx Biosystems and Plasmore, among others.

  • Headquarter Asse, Belgium
  • Employees 8 as on 31 Dec, 2015
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Pharma Diagnostics
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $7.4 M (USD)

    in 2 rounds

  • Latest Funding Round
    $3.7 M (USD), Series B

    Jan 21, 2010

  • Investors
    PMV

    & 3 more

  • Employee Count
    8

    as on Dec 31, 2015

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Pharma Diagnostics

Pharma Diagnostics has successfully raised a total of $7.4M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $3.7 million completed in January 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series B — $3.7M
  • First Round

    (12 Oct 2009)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2010 Amount Series B - Pharma Diagnostics Valuation

investors

Oct, 2009 Amount Series A - Pharma Diagnostics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Pharma Diagnostics

Pharma Diagnostics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include PMV, Cap-E and Capital E. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
US focused early-stage VC firm
Founded Year Domain Location
A venture capital fund focused on micro/nano-electronics is operated.
Founded Year Domain Location
Allegro Investment Fund is involved in investment activities.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Pharma Diagnostics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Pharma Diagnostics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Pharma Diagnostics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Pharma Diagnostics

Pharma Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Carterra, Nicoya Life, Riot Platforms, FOx Biosystems and Plasmore, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
SPR-based platforms are developed for enzyme kinetics studies.
domain founded_year HQ Location
Hyperspectral optical microscopes for surface analysis are provided.
domain founded_year HQ Location
Bitcoin mining solutions are offered by the platform.
domain founded_year HQ Location
Developer of fiber optic bio-sensing technology based on surface plasmon resonance
domain founded_year HQ Location
Develops nanoplasmon imaging technology
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Pharma Diagnostics

Frequently Asked Questions about Pharma Diagnostics

When was Pharma Diagnostics founded?

Pharma Diagnostics was founded in 2007 and raised its 1st funding round 2 years after it was founded.

Where is Pharma Diagnostics located?

Pharma Diagnostics is headquartered in Asse, Belgium. It is registered at Asse, Flemish Brabant, Belgium.

Who is the current CEO of Pharma Diagnostics?

Pierre Saelen is the current CEO of Pharma Diagnostics.

Is Pharma Diagnostics a funded company?

Pharma Diagnostics is a funded company, having raised a total of $7.4M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.7M, raised on Oct 12, 2009.

How many employees does Pharma Diagnostics have?

As of Dec 31, 2015, the latest employee count at Pharma Diagnostics is 8.

What does Pharma Diagnostics do?

Pharma Diagnostics was founded in 2007 in Asse, Belgium, and operates in the diagnostics sector. A technology platform for biomolecular interaction analysis is offered, centered on the proprietary SoPRano assay. This plate-based LSPR method employs gold nanomaterials conjugated to biomolecules, with absorbance changes detected on standard plate readers upon ligand binding. Applications encompass interaction kinetics, antibody screening, protein-protein interaction studies, and small molecule inhibition assays.

Who are the top competitors of Pharma Diagnostics?

Pharma Diagnostics's top competitors include Carterra, Nicoya Life and Riot Platforms.

Who are Pharma Diagnostics's investors?

Pharma Diagnostics has 4 investors. Key investors include PMV, Cap-E, Capital E, and Allegro Investment Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available